WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2005065682) RABEPRAZOLE CONTAINING FORMULATION
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2005/065682    International Application No.:    PCT/IN2004/000342
Publication Date: 21.07.2005 International Filing Date: 03.11.2004
IPC:
A61K 31/4184 (2006.01), A61K 47/26 (2006.01)
Applicants: LYKA LABS LIMITED [IN/IN]; 77, Nehru Road, Vile Parle (East), Mumbai - 400 099, Maharashtra (IN) (For All Designated States Except US).
BAJAJ, Mannalal, Ramgopal [IN/IN]; (IN) (For US Only).
SAMANT, Rajan, Shantaram [IN/IN]; (IN) (For US Only).
SHAH, Bharat, Babulal [IN/IN]; (IN) (For US Only)
Inventors: BAJAJ, Mannalal, Ramgopal; (IN).
SAMANT, Rajan, Shantaram; (IN).
SHAH, Bharat, Babulal; (IN)
Agent: NAIR, Gopakumar, G.; Patent & Trademark Agent (Regd.), Gopakumar Nair Associates, Nair Baug, Akurli Road, Kandivli (East), Mumbai - 400 101 (IN)
Priority Data:
1164/MUM/2003 05.11.2003 IN
Title (EN) RABEPRAZOLE CONTAINING FORMULATION
(FR) NOUVEAU SYSTEME D'ADMINISTRATION DE MEDICAMENT POUR INHIBITEURS DE POMPE A PROTONS ET SON PROCEDE
Abstract: front page image
(EN)The present invention discloses a novel drug delivery system for proton pump inhibitors comprising benzimidazole compounds or their salts, preferably Rabeprazole or its salts and pharmaceutically acceptable excipients in powder form which is reconstitutable in a parenterally acceptable solvent to form an injectable solution.
(FR)La présente invention concerne un nouveau système d'administration de médicament pour inhibiteurs de pompe à protons comprenant des composés benzimidazole ou leurs sels, de préférence le rabéprazole ou ses sels ainsi que des excipients pharmaceutiquement acceptables sous forme de poudre pouvant être reconstituée dans un solvant acceptable par voie parentérale pour former une solution injectable.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)